Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.

Journal of neuroimmunology - 1 Jan 2011

Tian Yingfang, Apperson Michelle L, Ander Bradley P, Liu Dazhi, Stomova Boryana S, Jickling Glen C, Enriquez Richelle, Agius Mark A, Sharp Frank R

Abstract excerpt

Using whole genome exon microarrays 120 exons were differentially expressed between medication-free multiple sclerosis (MS) subjects in remission and healthy control subjects (HS) (p<0.001, fold change>|1.2|). These exons differentiated MS from HS using cluster analyses, principal components analyses (PCAs) and cross-validation. In addition, 340 genes (transcripts) were predicted to be alternatively spliced in MS...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alternative Splicing
Share to Cluster Analysis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Gene Expression Profiling

Share to Multiple Sclerosis

Share to Oligonucleotide Array Sequence Analysis

Share to Principal Component Analysis

Share to Young Adult

Source

Identifiers

PMID: 20920832
DOI: 10.1016/j.jneuroim.2010.09.001

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Differences in exon expression and alternatively spliced genes in blood of multiple sclerosis compared to healthy control subjects.PMID 20920832Read ↗

The multiple sclerosis whole blood mRNA transcriptome and genetic associations indicate dysregulation of specific T cell pathways in pathogenesis.Semantic proximity Read ↗

Gene expression and alternative splicing analysis in a large-scale Multiple Sclerosis studySemantic proximity Read ↗

Gene Expression and Alternative Splicing Analysis in a Large-Scale Multiple Sclerosis Study.Semantic proximity Read ↗

Expression Analysis of Long Non-coding RNAs in the Blood of Multiple Sclerosis PatientsSemantic proximity Read ↗

Blood transcriptional signatures of multiple sclerosis: Unique gene expression of disease activitySemantic proximity Read ↗

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controlsSemantic proximity Read ↗

LncRNAs expression profile in peripheral blood mononuclear cells from multiple sclerosis patientsSemantic proximity Read ↗

Genetic and gene expression signatures in multiple sclerosis.Semantic proximity Read ↗

Global transcriptome profiling of mild relapsing‐remitting versus primary progressive multiple sclerosisSemantic proximity Read ↗

Dysregulation of MS risk genes and pathways at distinct stages of diseaseSemantic proximity Read ↗

Multiple sclerosis etiology: beyond genes and environment.Semantic proximity Read ↗

Gene expression profile in multiple sclerosis patients and healthy controls: identifying pathways relevant to diseaseSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.